Tweetby classifying amino acid derivative as 'unapproved drug'

Learn more: FDA destroys business of anti-aging supplement manufacturer by classifying amino acid derivative as 'unapproved drug'

uralNews) The U.S. Food and Drug Administration (FDA) has once again annihilated the business of a reputable dietary supplement company by arbitrarily declaring its primary product to be an "unapproved drug." Those who now try to purchase the all-natural, human growth hormone (hGH)-promoting Trans-D Tropin formula are greeted with a lengthy message notifying the public that the formula is no longer available, thanks to the tyrannical actions of a rogue government agency.

According to the Trans-D Tropin website, the FDA sent a letter to the supplement's manufacturer on April 26, 2013, notifying it that Trans-D Tropin is now recognized by the agency as an "unapproved drug." Even though Trans-D Tropin has been on the market for more than 15 years in full accordance with the legal guidelines of the Dietary Supplement Health Information Act (DSHEA) of 1994, the FDA suddenly, without precedent, decided that it is no longer permitted.

So to protect itself from potential legal action, the manufacturer of Trans-D Tropin decided to stop producing and selling it, at least for the time being. As of May 15, 2013, Trans-D Tropin can no longer be purchased by anyone, despite the fact that it has never been implicated in causing any serious side effects, and has never before been in violation of any of the legal provisions that guide how dietary supplements are to be manufactured and marketed.

"[W]ith virtually a 100 percent safety profile ... containing only amino acids and fatty acids, registered with the FDA for 14 years, with labels having been reviewed by the FDA, with annual inspections of the manufacturing facilities for over a decade with no major issues and concerns ... the FDA has declared that Trans-D Tropin is a 'drug,'" explains the new landing page for Trans-D Tropin.

FDA does not have authority to 'approve' dietary supplements, so it simply decrees that some of them are 'drugs'

Unlike pharmaceutical drugs, dietary supplements do not require FDA approval in order to be sold commercially, as they are typically natural, food-based substances. Dietary supplement manufacturers are only required to register their products with the FDA, which basically just means that they let the FDA know of their intent to sell a certain product. The FDA, in turn, is required to accept this registration and essentially leave the product alone.

Not being able to control the dietary supplement industry has long angered the FDA, which is filled with lust for assuming total control over all food, supplements, and drugs. When the FDA does not get its way -- or rather, when its Big Pharma handlers do not get their way -- the agency goes into tyrant mode and begins lashing out against companies that produce safe and effective nutritional compounds that more often than not compete with expensive pharmaceuticals.

"Never before has the FDA stated that Trans-D Tropin needed anything [other] than what the manufacturer obtained," explains the announcement. "In fact, the FDA resisted the manufacturer's attempts to register the product as far back as 1998. The initial response by the FDA was that Trans-D Tropin did NOT need to be 'registered' because it was only a cosmetic."

The FDA later accepted registration of Trans-D Tropin due to the fact that it is used as a dietary supplement and only contains natural ingredients. But the schizophrenic agency, which is obviously driven by some other sinister agenda, decided after 14 years of safe and effective use that Trans-D Tropin could no longer be sold to the public, which threatens to put the company out of business.

You can read the full announcement about the FDA's new drug classification for Trans-D Tropin here:
Trans-D Tropin Re-Classified by FDA, Leads To Changes - Trans-D Tropin®

Reform or disband, the only two options for dealing with extreme FDA corruption

A quick look into the history of Trans-D Tropin reveals that the product has been a huge success in helping people to boost their hGH levels and modulate their insulin-like growth factor 1 (IGF-1) levels -- too much IGF-1 has been linked to increased cancer risk. So it is no wonder that the FDA wants this incredible anti-aging product off the market, as it threatens to undermine the viability of the drug industry.

"The agenda of many agencies involved in health care has become highly suspect and their motivation is even more sinister when things such as mercury (as found in dental amalgams) are allowed to be used and mercury (as found in vaccines as a preservative called thimerosal) continue to be used," adds the Trans-D Tropin discontinuation announcement.

"Why are products like Trans-D Tropin, or Apricot seeds (laetrile) or numerous other natural substances that have only helped people, not allowed to be sold to the public? What type of world are we creating to leave behind for our children's generation?"

Learn more: FDA destroys business of anti-aging supplement manufacturer by classifying amino acid derivative as 'unapproved drug'

TweetBiggun, you said it well...too often are duties and obligations just passed-down to administrative agencies such as the FDA...I cannot believe that this supplement of all things was targeted! I have never heard anything bad about it yet it was targeted...I am not a conspiracy theorist; however, this f*cking wreaks of injustice